Rajan Wadhawan, MD

Overview

Rajan Wadhawan, MD, MMM is the Senior Executive Officer for AdventHealth for Children and AdventHealth for Women. He holds a faculty appointment as an Associate Professor at the University of Central Florida, Department of Pediatrics. Dr. Wadhawan completed his training in pediatrics and neonatology at Brown University in Providence, Rhode Island. Dr. Wadhawan obtained a master’s degree in Medical Management from Carnegie Mellon University in 2011. He is also board certified in Pediatrics, Neonatal Perinatal Medicine and Medical Management by the Certifying Commission for Medical Management as a Certified Physician Executive (CPE). Dr. Wadhawan previously served as Chief Medical Officer and Medical Director of Neonatology at AdventHealth for Children. During his tenure as Chief Medical Officer, Dr. Wadhawan oversaw the accomplishment of several landmarks regarding quality and safety of care including recognition as a LeapFrog Top Children’s Hospital and US News recognition as a top Neonatology program in the country. Dr. Wadhawan is also responsible for physician strategy related to growth and expansion of clinical service lines for AdventHealth for Children. His research focuses on factors that impact neurodevelopmental outcomes in extremely premature infants.

Articles

Maternal recorded voice played to preterm infants in incubators reduces her own depression, anxiety and stress: a pilot randomized control trial

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE

2024

Withdrawal of artificial nutrition and hydration: a survey of level IV neonatal intensive care units

JOURNAL OF PERINATOLOGY

2021

Severity and Cost of RSV Hospitalization Among US Preterm Infants Following the 2014 American Academy of Pediatrics Policy Change

INFECTIOUS DISEASES AND THERAPY

2021

Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant

PEDIATRIC RESEARCH

2021

Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial

JAMA PEDIATRICS

2020

Center, Gestational Age, and Race Impact End-of-Life Care Practices at Regional Neonatal Intensive Care Units

JOURNAL OF PEDIATRICS

2020

Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)

PEDIATRIC RESEARCH

2020

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

NEW ENGLAND JOURNAL OF MEDICINE

2020

Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants

JOURNAL OF PERINATOLOGY

2019

Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia

JOURNAL OF PINEAL RESEARCH

2019

Associated Clinical Trials

Children's Hospitals Neonatology Consortium (CHNC): Data Sharing and Quality Improvement Initiative

The complex high acuity-patient population seen in tertiary NICU's located in major children's hospitals across the nation is a unique predominately referral population, not seen in most NICU's supported by in-ho ...

Rajan Wadhawan , MD

Overview

Articles

Maternal recorded voice played to preterm infants in incubators reduces her own depression, anxiety and stress: a pilot randomized control trial

Withdrawal of artificial nutrition and hydration: a survey of level IV neonatal intensive care units

Severity and Cost of RSV Hospitalization Among US Preterm Infants Following the 2014 American Academy of Pediatrics Policy Change

Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant

Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial

Center, Gestational Age, and Race Impact End-of-Life Care Practices at Regional Neonatal Intensive Care Units

Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants

Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia

Education & Training

Education

Residency

Fellowship

Board Certifications

Associated Clinical Trials

Children's Hospitals Neonatology Consortium (CHNC): Data Sharing and Quality Improvement Initiative

Explore

Institutes